Jonathan Saltzman

Jonathan Saltzman has worked at the Boston Globe since 2002 and currently covers biotechnology and the life sciences. He previously covered the federal and state courts and then spent six years on the Spotlight Team. He was part of a team that won a George Polk Award in 2012 for a series on the state’s unusually high rate of acquittal at bench trials for drunk driving. He was also a runner-up for other awards, including a Pulitzer Prize and Goldsmith Prize for Investigative Reporting, for a series of stories about dangerous off-campus housing for college students in Boston. Saltzman, a graduate of Brooklyn College, has worked at the Providence Journal, USA Today, the Rochester Democrat & Chronicle, and the Poughkeepsie Journal. He also co-hosted a daily magazine show for the NPR station in Rhode Island. He lives in Providence.

Latest stories

A Boston biotech takes on a challenge most companies have avoided: making a better schizophrenia drug

By , Globe Staff

Karuna Pharmaceuticals is working on what would be the first dramatically new treatment for the disease in decades.

Against the odds, tiny Waltham biotech strives to improve dialysis patients’ lives

By , Globe Staff

The firm of 17 employees has been working on a drug, despite major setbacks, for more than 12 years.

For biotech, 2019’s not a sky’s-the-limit year

By , Globe Staff

The stock market’s sharp decline in the last quarter of 2018 has many Americans worried. But the tumble was particularly brutal for the state’s high-flying biotech sector.

Ironwood CEO stepping down to run spinoff biotech

By , Globe Staff

Peter Hecht will head the newly named Cyclerion Therapeutics.